{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T14:33:37Z","timestamp":1715610817874},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s00393-023-01430-6","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T08:02:34Z","timestamp":1695801754000},"page":"297-302","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Multifocal leukoencephalopathy in a\u00a0patient medicated with etanercept and methotrexate for rheumatoid arthritis","Multifokale Leukenzephalopathie bei einer Patientin mit Etanercept und Methotrexat gegen rheumatoide Arthritis"],"prefix":"10.1007","volume":"83","author":[{"given":"Tieer","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,27]]},"reference":[{"key":"1430_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2165\/00019053-200422001-00005","volume":"22","author":"LW Moreland","year":"2004","unstructured":"Moreland\u00a0LW (2004) Drugs that block tumour necrosis factor: experience in patients with rheumatoid arthritis. Pharmacoeconomic 22:39\u201353","journal-title":"Pharmacoeconomic"},{"key":"1430_CR2","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1158\/1055-9965.EPI-21-0125","volume":"30","author":"ME D\u2019arcy","year":"2021","unstructured":"D\u2019arcy\u00a0ME, Beachler\u00a0DC, Pfeiffer\u00a0RM et\u00a0al (2021) Tumor necrosis factor inhibitors and the risk of cancer among older Americans with rheumatoid arthritis. Cancer Epidemiol Biomarkers Prev 30:2059\u20132067","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1430_CR3","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.ccm.2019.07.003","volume":"40","author":"MS Godfrey","year":"2019","unstructured":"Godfrey\u00a0MS, Friedman\u00a0LN (2019) Tuberculosis and biologic therapies: anti-tumor necrosis factor\u2011\u03b1 and beyond. Clin Chest Med 40:721\u2013739","journal-title":"Clin Chest Med"},{"key":"1430_CR4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3109\/s10165-008-0062-z","volume":"18","author":"T Kameda","year":"2008","unstructured":"Kameda\u00a0T, Dobashi\u00a0H, Kittaka\u00a0K et\u00a0al (2008) A case of rheumatoid arthritis complicated by demyelination in both cerebral cortex and spinal cord during etanercept therapy. Mod Rheumatol 18:399\u2013402","journal-title":"Mod Rheumatol"},{"key":"1430_CR5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3109\/s10165-006-0530-2","volume":"17","author":"M Yamamoto","year":"2007","unstructured":"Yamamoto\u00a0M, Takahashi\u00a0H, Wakasugi\u00a0H et\u00a0al (2007) Leukoencephalopathy during administration of etanercept for refractory rheumatoid arthritis. Mod Rheumatol 17:72\u201374","journal-title":"Mod Rheumatol"},{"key":"1430_CR6","first-page":"99","volume":"2","author":"WH Ibrahim","year":"2007","unstructured":"Ibrahim\u00a0WH, Hammoudah\u00a0M, Akhtar\u00a0N et\u00a0al (2007) Central nervous system demyelination associated with etanercept in a\u00a051\u00a0years old woman. Libyan J Med 2:99\u2013102","journal-title":"Libyan J Med"},{"key":"1430_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2014-205779","author":"W Yokoyama","year":"2014","unstructured":"Yokoyama\u00a0W, Takada\u00a0K, Miyasaka\u00a0N et\u00a0al (2014) Myelitis and optic neuritis induced by a\u00a0long course of etanercept in a\u00a0patient with rheumatoid arthritis. BMJ Case Rep. https:\/\/doi.org\/10.1136\/bcr-2014-205779","journal-title":"BMJ Case Rep"},{"key":"1430_CR8","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jaad.2005.05.039","volume":"54","author":"SA Sukal","year":"2006","unstructured":"Sukal\u00a0SA, Nadiminti\u00a0L, Granstein\u00a0RD (2006) Etanercept and demyelinating disease in a\u00a0patient with psoriasis. J\u00a0Am Acad Dermatol 54:160\u2013164","journal-title":"J Am Acad Dermatol"},{"key":"1430_CR9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.2174\/1573397112666160824151801","volume":"12","author":"AN Malaviya","year":"2016","unstructured":"Malaviya\u00a0AN (2016) Low-dose methotrexate (LD-MTX) in rheumatology practice\u2014A most widely misunderstood drug. Curr Rheumatol Rev 12:168\u2013176","journal-title":"Curr Rheumatol Rev"},{"key":"1430_CR10","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3340\/jkns.2011.50.4.304","volume":"50","author":"JY Kim","year":"2011","unstructured":"Kim\u00a0JY, Kim\u00a0ST, Nam\u00a0DH et\u00a0al (2011) Leukoencephalopathy and disseminated necrotizing leukoencephalopathy following intrathecal methotrexate chemotherapy and radiation therapy for central nerve system lymphoma or leukemia. J\u00a0Korean Neurosurg Soc 50:304\u2013310","journal-title":"J Korean Neurosurg Soc"},{"key":"1430_CR11","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/PPO.0000000000000449","volume":"26","author":"CE Correia","year":"2020","unstructured":"Correia\u00a0CE, Schaff\u00a0LR, Grommes\u00a0C (2020) Central nervous system lymphoma: approach to diagnosis and treatment. Cancer\u00a0J 26:241\u2013252","journal-title":"Cancer J"},{"key":"1430_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3892\/br.2014.380","volume":"3","author":"P Zhang","year":"2015","unstructured":"Zhang\u00a0P, Li\u00a0X, Li\u00a0Y et al (2015) Reversible posterior leukoencephalopathy syndrome secondary to systemic-onset juvenile idiopathic arthritis: A\u00a0case report and review of the literature. Biom Rep 3:55\u201358","journal-title":"Biom Rep"},{"key":"1430_CR13","doi-asserted-by":"crossref","first-page":"e005053","DOI":"10.1099\/jmmcr.0.005053","volume":"3","author":"MJ De Regt","year":"2016","unstructured":"De Regt\u00a0MJ, Murk\u00a0JL, Schneider-Hohendorf\u00a0T et al (2016) Progressive multifocal leukoencephalopathy and black fungus in a\u00a0patient with rheumatoid arthritis without severe lymphocytopenia. JMM Case Rep 3:e5053","journal-title":"JMM Case Rep"},{"key":"1430_CR14","doi-asserted-by":"publisher","first-page":"746396","DOI":"10.3389\/fphar.2021.746396","volume":"12","author":"J Li","year":"2021","unstructured":"Li\u00a0J, Zhang\u00a0Z, Wu\u00a0X et al (2021) Risk of adverse events after anti-TNF treatment for inflammatory rheumatological disease. A\u00a0meta-analysis. Front Pharmacol 12:746396","journal-title":"Front Pharmacol"},{"key":"1430_CR15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11910-017-0742-1","volume":"17","author":"E Kemanetzoglou","year":"2017","unstructured":"Kemanetzoglou\u00a0E, Andreadou\u00a0E (2017) CNS demyelination with TNF\u2011\u03b1 Blockers. Curr Neurol Neurosci Rep 17:36","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1430_CR16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4081\/reumatismo.2019.1115","volume":"71","author":"V Shobha","year":"2019","unstructured":"Shobha\u00a0V, Desai\u00a0AM, Matthew\u00a0T (2019) Etanercept biosimilar associated with Guillain-Barr\u00e9 syndrome: insights from a\u00a0case. Reumatismo 71:99\u2013102","journal-title":"Reumatismo"},{"key":"1430_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12348-020-00202-6","volume":"10","author":"F Nicolela Susanna","year":"2020","unstructured":"Nicolela Susanna\u00a0F, Pavesio\u00a0C (2020) A review of ocular adverse events of biological anti-TNF drugs. J\u00a0Ophthal Inflamm Infect 10:11","journal-title":"J Ophthal Inflamm Infect"},{"key":"1430_CR18","doi-asserted-by":"publisher","unstructured":"Finke C, Schmidt W, Siebert E et al (2015) Etanercept-associated myelitis. Oxf Med Case Rep: 220\u2013221. \nhttps:\/\/doi.org\/10.1093\/omcr\/omv015","DOI":"10.1093\/omcr\/omv015"},{"key":"1430_CR19","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.4103\/0028-3886.190240","volume":"64","author":"E Gali\u00e8","year":"2016","unstructured":"Gali\u00e8\u00a0E, Jandolo\u00a0B, Martayane\u00a0A et al (2016) Multiple sclerosis activated by anti-tumor necrosis factor \u03b1 (Etanercept) and the genetic risk. Neurol India 64:1042\u20131044","journal-title":"Neurol India"},{"key":"1430_CR20","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s12185-018-2525-0","volume":"108","author":"K Watanabe","year":"2018","unstructured":"Watanabe\u00a0K, Arakawa\u00a0Y, Oguma\u00a0E et al (2018) Characteristics of methotrexate-induced stroke-like neurotoxicity. Int J Hematol 108:630\u2013636","journal-title":"Int J Hematol"},{"key":"1430_CR21","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1089\/jir.2020.0012","volume":"40","author":"T Asano","year":"2020","unstructured":"Asano\u00a0T, Iguchi\u00a0A, Miyasho\u00a0T (2020) Interleukin-6-mediated inflammation may cause methotrexate-induced leukoencephalopathy. J\u00a0Interferon Cytokine Res 40:341\u2013348","journal-title":"J Interferon Cytokine Res"},{"key":"1430_CR22","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s12311-013-0528-1","volume":"13","author":"I Gonz\u00e1lez-Su\u00e1rez","year":"2014","unstructured":"Gonz\u00e1lez-Su\u00e1rez\u00a0I, Aguilar-Amat\u00a0MJ, Trigueros\u00a0M et al (2014) Leukoencephalopathy due to oral methotrexate. Cerebellum 13:178\u2013183","journal-title":"Cerebellum"},{"key":"1430_CR23","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00401-007-0214-9","volume":"114","author":"H Yokoo","year":"2007","unstructured":"Yokoo\u00a0H, Nakazato\u00a0Y, Harigaya\u00a0Y et al (2007) Massive myelinolytic leukoencephalopathy in a\u00a0patient medicated with low-dose oral methotrexate for rheumatoid arthritis: an autopsy report. Acta Neuropathol 114:425\u2013430","journal-title":"Acta Neuropathol"},{"key":"1430_CR24","doi-asserted-by":"publisher","first-page":"292","DOI":"10.4103\/0973-1482.98993","volume":"8","author":"PR Salkade","year":"2012","unstructured":"Salkade\u00a0PR, Lim\u00a0TA (2012) Methotrexate-induced acute toxic leukoencephalopathy. J\u00a0Can Res Ther 8:292\u2013296","journal-title":"J Can Res Ther"},{"key":"1430_CR25","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1468-1331.2006.01659.x","volume":"14","author":"S Raghavendra","year":"2007","unstructured":"Raghavendra\u00a0S, Nair\u00a0MD, Chemmanam\u00a0T et al (2007) Disseminated necrotizing leukoencephalopathy following low-dose oral methotrexate. Eur J Neurol 14:309\u2013314","journal-title":"Eur J Neurol"},{"key":"1430_CR26","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00234-003-0983-3","volume":"45","author":"M Oka","year":"2003","unstructured":"Oka\u00a0M, Terae\u00a0S, Kobayashi\u00a0R et al (2003) MRI in methotrexate-related leukoencephalopathy: Disseminated necrotising leukoencephalopathy in comparison with mild leukoencephalopathy. Neuroradiology 45:493\u2013497","journal-title":"Neuroradiology"},{"key":"1430_CR27","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1007\/s00415-016-8377-8","volume":"264","author":"M Fischer","year":"2017","unstructured":"Fischer\u00a0M, Schmutzhard\u00a0E (2017) Posterior reversible encephalopathy syndrome. J\u00a0Neurol 264:1608\u20131616","journal-title":"J Neurol"},{"key":"1430_CR28","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/BF00604796","volume":"38","author":"Y Ohmoto","year":"1996","unstructured":"Ohmoto\u00a0Y, Kajiwara\u00a0K, Kato\u00a0S et al (1996) Atypical MRI findings in treatment-related leukoencephalopathy: case report. Neuroradiology 38:128\u2013133","journal-title":"Neuroradiology"},{"key":"1430_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41582-020-00427-y","volume":"17","author":"I Cortese","year":"2021","unstructured":"Cortese\u00a0I, Reich\u00a0DS, Nath\u00a0A (2021) Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease. Nat Rev Neurol 17:37\u201351","journal-title":"Nat Rev Neurol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-023-01430-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-023-01430-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-023-01430-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T06:04:59Z","timestamp":1714370699000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-023-01430-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,27]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["1430"],"URL":"https:\/\/doi.org\/10.1007\/s00393-023-01430-6","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,27]]},"assertion":[{"value":"25 August 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"T.\u00a0Yu and C.\u00a0Yang declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case. For images or other information within the manuscript which identify patients, consent was obtained from them and\/or their legal guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}